DarioHealth Corp.
DRIO · Surgical & Medical Instruments & Apparatus · 7.3M shares · -20%/yr ↓ buyback · EDGAR filings ↗
Net buyback after stock comp: $88K (gross $134K, SBC $46K)
Reference price $0.53 · est. market cap ~$4M — last insider purchase, 2025-08-27 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D44Digital-health (diabetes) company with operating losses and cash burn.
Strengths
- Adequate liquidity — current ratio 3.8 (56th)
Risks
- Operating/net losses — ROE -61%, ROA -38%
- Cash burn — FCF -$26M
- Reimbursement/adoption execution — per 10-K
Notable findings
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Cash burnNegative free cash flow (-26.1M)
- Exec changeRecent 8-K item 5.02 8-K ↗
- Buying back stockNet buyback — share count -20%/yr over 4y
- Notable holderHeld by 1 notable fund(s): CITADEL ADVISORS LLC (as of 2026-03-31)
- New fund positionNotable fund(s) opened this quarter: CITADEL ADVISORS LLC
- Pending merger(“Merger Sub”), Twill and Bilal Khan, solely in his capacity as the representatives of Twill’s stockholders and other equity holders, entered into an Agreement and Plan of Merger (the “Merger Agreemen
- Revenue declineRevenue -26.4% YoY
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Return on equity
-61.4%
Return on assets
-37.9%
ROIC
-29.3%
Revenue growth (QoQ)
-26.4%
Debt / equity
0.5×
Current ratio
3.8×
Free cash flow
-$26M
Tangible book value
-$5M
Cash & investments
$22M
Cash runway
3q
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2025-09-11 | Nelson Steven Charles | Grant | 30K | — |
| 2025-09-11 | STERN ADAM K | Grant | 20K | — |
| 2025-09-11 | Leisure Lawrence B. | Grant | 20K | — |
| 2025-09-11 | Shaked Yoav | Grant | 20K | — |
| 2025-09-11 | Raphael Erez | Grant | 60K | — |
| 2025-09-11 | Franco-Yehuda Chen | Grant | 5.0K | — |
| 2025-09-11 | MCGRATH DENNIS M | Grant | 20K | — |
| 2025-09-11 | Karah Hila | Grant | 20K | — |
| 2025-09-11 | Matheis Dennis | Grant | 20K | — |
| 2025-08-27 | Nelson Steven Charles | Buy | 40K | $0.53 |
| 2025-05-15 | Franco-Yehuda Chen | Grant | 500K | — |
| 2025-02-24 | KAPLAN JON H. | Grant | 30K | — |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-04-13 | Exec/director changeOtherExhibits | filing ↗ |
| 2026-03-30 | Material agreementExhibits | filing ↗ |
| 2026-02-02 | 5.03Exhibits | filing ↗ |
| 2026-01-29 | Shareholder vote | filing ↗ |
| 2025-11-10 | Material agreementDebt obligation3.02Exhibits | filing ↗ |
| 2025-09-25 | Material agreement3.025.03OtherExhibits | filing ↗ |
| 2025-09-19 | 3.035.03Exhibits | filing ↗ |
| 2025-09-12 | Other | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 10-Q | 2026-05-13 | 2026-03-31 | 0001104659-26-059676 ↗ |
| 8-K | 2026-04-13 | 2026-04-10 | 0001104659-26-042362 ↗ |
| 8-K | 2026-03-30 | 2026-03-30 | 0001104659-26-036834 ↗ |
| 10-K | 2026-03-19 | 2025-12-31 | 0001104659-26-031621 ↗ |
| 8-K | 2026-02-02 | 2026-02-02 | 0001104659-26-009247 ↗ |
| 8-K | 2026-01-29 | 2026-01-29 | 0001104659-26-007974 ↗ |
| 10-Q | 2025-11-13 | 2025-09-30 | 0001104659-25-110730 ↗ |
| 8-K | 2025-11-10 | 2025-11-05 | 0001104659-25-109166 ↗ |
| 8-K | 2025-09-25 | 2025-09-25 | 0001104659-25-093431 ↗ |
| 8-K | 2025-09-19 | 2025-09-18 | 0001104659-25-091718 ↗ |
| 8-K | 2025-09-12 | 2025-09-12 | 0001104659-25-089629 ↗ |
| 8-K | 2025-08-25 | 2025-08-25 | 0001104659-25-082513 ↗ |